At Panelav
Alembic Pharmaceuticals announced that the United States Food and Drug Administration (US FDA) has conducted an inspection at Alembic Pharmaceuticals API Facility located at Panelav from 16 April, 2018 to 23 April, 2018. This was a scheduled inspection and at the end of the inspection, there were zero 483s.Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content